BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8736161)

  • 1. [Dystonia: therapeutic aspects].
    Papaterra Limongi JC
    Arq Neuropsiquiatr; 1996 Mar; 54(1):147-55. PubMed ID: 8736161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of dystonia.
    Adam OR; Jankovic J
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S362-8. PubMed ID: 18267265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in the treatment of the dystonias].
    Giménez-Roldán S
    Arch Neurobiol (Madr); 1991; 54(5):198-205. PubMed ID: 1804033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in the treatment of the dystonias].
    Giménez-Roldán S
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():32-9. PubMed ID: 1810206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adduction spastic dysphonia: clinical and treatment].
    García Ruiz PJ; Sánchez del Río M; Cenjor Español C; Sanabria Brassart J; Sánchez Bernardos V; Astarloa Gómez R; García de Yébenes J
    Rev Clin Esp; 1998 Mar; 198(3):156-8. PubMed ID: 9586438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystonia--a clinical, neuropathological and therapeutic review.
    Wissel J; Poewe W
    J Neural Transm Suppl; 1992; 38():91-104. PubMed ID: 1491251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status and prospects of medical therapy for dystonia].
    Osawa M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):967-9. PubMed ID: 17432235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A survey about the accessibility to botulinum toxin therapy for dystonia].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parkinsonian dystonia].
    Dowsey-Limousin P
    Rev Neurol (Paris); 2003 Oct; 159(10 Pt 1):928-31. PubMed ID: 14615683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ; Charles PD; Davis TL; Robertson D
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of dystonia.
    Jankovic J
    Lancet Neurol; 2006 Oct; 5(10):864-72. PubMed ID: 16987733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin treatment of occupational and focal hand dystonia.
    Karp BI
    Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study and treatment of dystonias in childhood].
    Pascual-Pascual SI
    Rev Neurol; 2006 Oct; 43 Suppl 1():S161-8. PubMed ID: 17061184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of focal dystonia with botulinic toxin].
    Gracia F; Castillo LC
    Rev Med Panama; 1996 Sep; 21(3):121-31. PubMed ID: 9280925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
    Calne S
    Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.